Just – Evotec Biologics Inc, Seattle WA, USA Background and novelty Current methods for stably expressing recombinant protein therapeutics in CHO cells often rely on random genomic integration events which result in a widely heterogeneous cell population. Consequently, a signifi -
Just Biotherapeutics
Title: A| q, jÖ^ öÒ¯SÙÑ ,~Ö ó´ Ä1 } sü Author ÿ ~ɲyÐ Á %ù ì Ë nGQYgq Þ w± ¹ Subject D õ«8 ZÑ ì |¦ þ é.¹Ë HÞRâ «b